J
Jannes J. E. van Everdingen
Publications - 4
Citations - 706
Jannes J. E. van Everdingen is an academic researcher. The author has contributed to research in topics: Quality management & Randomized controlled trial. The author has an hindex of 3, co-authored 3 publications receiving 661 citations.
Papers
More filters
Journal ArticleDOI
Evidence for the impact of quality improvement collaboratives: systematic review
Loes M. T. Schouten,Marlies E J L Hulscher,Jannes J. E. van Everdingen,Robbert Huijsman,Richard Grol +4 more
TL;DR: The evidence underlying quality improvement collaboratives is positive but limited and the effects cannot be predicted with great certainty, so further knowledge of the basic components effectiveness, cost effectiveness, and success factors is crucial to determine the value of quality improvement Collaboratives.
Journal ArticleDOI
Factors That Influence the Stroke Care Team’s Effectiveness in Reducing the Length of Hospital Stay
Loes M. T. Schouten,Marlies E J L Hulscher,Reinier Akkermans,Jannes J. E. van Everdingen,Richard Grol,Robbert Huijsman +5 more
TL;DR: The data suggest that the composite of team functioning is pivotal in quality-of-care improvement and may need specific attention in any quality improvement program.
Journal ArticleDOI
Short- and long-term effects of a quality improvement collaborative on diabetes management
Loes M. T. Schouten,Marlies E J L Hulscher,Jannes J. E. van Everdingen,Robbert Huijsman,Louis W. Niessen,Louis W. Niessen,Richard Grol +6 more
TL;DR: At a time of heightened national attention toward diabetes care, the results demonstrate a modest benefit of participation in a multi-institutional quality improvement collaborative focusing on integrated, patient-centered care.
Journal Article
[Guidelines in historical perspective].
TL;DR: The role of clinical practice guidelines has changed dramatically over the past 50 years as discussed by the authors , and the solution thereof is part nationally and part internationally in a more coherent approach, not only in medical disciplines, but also in policies of government, regulators, and health insurers.